Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Evidence Generation

Employer
Freenome
Location
South San Francisco, CA
Start date
Jan 3, 2022

Job Details

Director, Evidence Generation (Scientific and Medical Affairs)

About the Role

In this newly created role, the Director, Evidence Generation will lead the generation of clinical evidence needed to support product development, regulatory approval, coverage and reimbursement, and commercialization for Freenome’s CRC and multicancer early detection tests.

You will partner with internal stakeholders (e.g., Biostatistics and Epidemiology, Reimbursement and Health Policy, Commercial, Clinical Development) as well as external collaborators, advisors, and KOLs to identify evidence gaps and lead the design, execution, analysis, and publication of studies, including those focused on clinical utility, Health Economics and Outcomes Research (HEOR), and real-world data (RWD), to support product launch and post-launch commercialization activities.

How you’ll contribute:

  • Identify evidence gaps and lead evidence-generating studies to support product development for both CRC and multicancer products, with a focus on clinical utility, HEOR, and RWD 
  • Build Freenome’s investigator-initiated research program
  • Information gathering, analysis, and creation of medical/technical content for internal and external use 
  • Generation of accurate and up-to-date scientific and medical content for internal and external audiences
  • Review and approval for all external-facing company developed materials (Clinical, Medical, and Commercial), as part of a cross-functional review committee
  • Generation of FAQs and responses for HCPs and KOLs as part of building medical information capabilities
  • Develop high-quality presentations to support product communications, including educational content, for early cancer detection tests to internal stakeholders and external audiences, including HCPs, KOLs, patient advocacy groups, regulators, and payers
  • Present data via posters and abstracts at scientific and clinical conferences

What you’ll bring: 

  • M.D. or Ph.D. degree with at least five years of industry experience in Medical Affairs, Scientific Affairs, or Clinical Development; or MS degree with ten years of similar experience
    • Experience designing, executing, and publishing studies focused on clinical utility, HEOR, and RWD
    • Experience with FDA-cleared or approved Dx products
  • Advanced training in immunology, oncology, epidemiology, pharmacology, diagnostics, or therapeutics
  • Strong scientific, medical, or technical writing and presentation skills
  • Experience designing, executing, and publishing studies focused on clinical utility, HEOR, and RWD
  • Experience with FDA-cleared or approved Dx products
  • Ability to transition between being accountable for projects and supporting projects, as needed
  • Ability to navigate changing conditions, processes, and strategies while working collaboratively across the organization
  • Ability to travel up to 20%

Freenome’s contribution: 

  • Competitive compensation 
  • Pre-IPO equity
  • Flexible PTO (exempt) and generous PTO (non-exempt) 
  • Comprehensive health coverage, including medical, dental, and vision 
  • Wellness and mental health resources, including Employee Assistance Programs (EAPs), Paid maternity and paternity leave
  • 401(k) plan 
  • $250.00 new hire stipend to enhance your home office experience
  • Plus, a variety of other perks, including pre-tax commuter benefits, two paid volunteer days per year, pet insurance, and additional discounts. 

 

Freenome has adopted a COVID-19 vaccination policy to safeguard the health and well-being of our employees. As a condition of employment, our employees working on-site are required to be fully vaccinated for COVID-19, unless a reasonable accommodation is approved or as otherwise required by law.

About Our Science

We’re building technology to advance the understanding of cancer through multiple analytes derived from blood. These signals include cell-free DNA, methylation of cell-free DNA, cell-free RNA, circulating proteins and immune profiling from thousands of prospective samples. 

By developing novel statistical learning methods and applying them to integrate various -omics datasets, we’ve become a leader in modeling specific biological mechanisms. This means we’re capturing disease-dependent signatures, including gene expression, immune response, tumor burden, the tissue of origin and 3D chromatin structure. 

By building comprehensive discovery datasets and modeling critical biological systems, we’re learning the biological changes present in the blood during different stages of cancer. 

Our Culture

Freenomers are technical, creative, visionary, grounded, empathetic and passionate. We build teams around divergent expertise, allowing us to solve problems and ascertain opportunities in unique ways. Freenomers are some of the most talented experts in their fields, joining together to advance healthcare, one breakthrough at a time. 

We value empathy, integrity and trust in one another. We respect the diverse perspectives of our colleagues and those we serve.  We assume positive intent and give each other the benefit of the doubt with the firm belief that we are a team working toward the same objectives.  We believe in empowering and supporting each other in a collaborative and dynamic environment. 

What does a successful person look like at Freenome?

Those who thrive at Freenome prioritize, manage and execute their own goals with ownership and alignment with those of the company. They embrace our values of empathy, integrity, striving for greatness, servant leadership, trust, and holding themselves and their team accountable to these values. 

They crave collaboration with brilliant minds from disparate fields of study and believe that hiring and mentorship are fundamental to our success. Above all, they welcome and provide constructive feedback and criticism, trusting in others’ good intentions and being secure in knowing that embracing mistakes is the best way to learn and grow. 

For those who pursue challenges, understudied problems and want the opportunity to see their work impact the lives of millions of people affected by cancer every year, there’s no better place to be than Freenome.

# # # 

Freenome is proud to be an equal opportunity employer and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.

Applicants have rights under Federal Employment Laws.  

 

LI-#Remote

 

 

Company

Mission

Freenome is a high growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.

Approach

To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. 

Funding

We have raised more than $1.1B from leading investors including Andreessen Horowitz, Bain Capital, GV, Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Novartis, Verily, and more. 

Freenomers

A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career. 

 

Facebook     Twitter  

Company info
Website
Phone
(650) 446-6630
Location
279 East Grand Avenue
5th Floor
South San Francisco
California
94080
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert